Although numbers were small, intravenous corticosteroid use (eg, at enrolment 52 patients treated with intravenous corticosteroids, 28 of whom received ≥3 ‘pulses’) also showed a trend towards being associated with MetS (OR 1.60, 95% CI 0.87 to 2.97).
← all excerpts
Impact of early disease factors on metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort.
1
—
—